LDHA is highly expressed in MM cell lines, and targeting LDHA is considered a novel therapeutic approach, while the potential mechanism for LDHA upregulation remains unclear (Fujiwara et al., 2013; Maiso et al., 2015). Here, LDHA is linked to Miyoshi myopathy.